European Union Drugs Agency. (2026) MDMA – the current situation in Europe (European drug report 2026). Lisbon: EUDA.
External website: https://www.euda.europa.eu/publications/european-d...
MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in nightlife and entertainment settings. On this page, you can find the latest analysis of the drug situation for MDMA in Europe, including prevalence of use, seizures, price and purity and more.
This page is part of the European Drug Report 2026, the EUDA’s annual overview of the drug situation in Europe.
A Substance use and dependence > Substance related societal (social) problems / harms
B Substances > CNS stimulants > MDMA / Ecstasy
E Concepts in biomedical areas > Pharmacology and toxicology > Potency / strength
E Concepts in biomedical areas > Pharmacology and toxicology > Purity / adulterant
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Hospital
MM-MO Crime and law > Substance related offence > Drug offence > Illegal production of drugs
MM-MO Crime and law > Substance related offence > Drug offence > Illegal distribution of drugs (drug market / dealing)
MM-MO Crime and law > Substance related offence > Drug offence > Illegal drug possession (seizures)
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
P Demography, epidemiology, and history > Population dynamics / statistics > Substance related mortality / death
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page